Published in Ann Neurol on December 01, 1991
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol (2010) 1.42
Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J Neuroimmunol (2008) 1.25
Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun (1996) 1.25
The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr Mol Med (2009) 1.10
Heat shock protein 70: roles in multiple sclerosis. Mol Med (2012) 0.87
Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration. Acta Neuropathol Commun (2014) 0.83
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cell Immunol (2014) 0.80
Gamma delta T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions. Mol Med (1995) 0.78
γδ T Cells and NK Cells - Distinct Pathogenic Roles as Innate-Like Immune Cells in CNS Autoimmunity. Front Immunol (2015) 0.77
gammadelta T cells: the overlooked T-cell subset in demyelinating disease. J Neurosci Res (2010) 0.77
Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival. J Neuroimmunol (2009) 0.77
Heat shock proteins as targets for gamma-delta T cells in multiple sclerosis. Ann Neurol (1992) 0.75
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol (2001) 3.59
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol (1995) 1.27
Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27
MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol (1998) 1.26
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med (1984) 1.23
Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol (2001) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J Immunol (2001) 1.18
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain (1999) 1.17
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia (2007) 1.16
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol (1981) 1.12
Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res (1996) 1.11
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Inhibition of medulloblastoma cell invasion by Slit. Oncogene (2006) 1.09
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol (1995) 1.04
A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol (1995) 1.04
Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J Cell Biochem (1995) 1.03
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections. Immunol Rev (1997) 1.03
Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest (1996) 1.02
IL-10 production by adult human derived microglial cells. Neurochem Int (1996) 1.02
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol (1996) 1.00
Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
The privacy of T cell memory to viruses. Curr Top Microbiol Immunol (2006) 0.98
CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol (2000) 0.98
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci (1995) 0.98
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery (1991) 0.97
Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol (2000) 0.96
Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology (2000) 0.95
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol (1982) 0.94
Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol (2000) 0.93
Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann Neurol (1999) 0.93
p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci (1998) 0.93
T cell regulation of polyclonally induced immunoglobulin secretion in humans. J Immunol (1984) 0.93
Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J Immunol (1999) 0.92
Immunohistochemical studies of adult human glial cells. J Neuroimmunol (1989) 0.92
Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol (1987) 0.92
NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol (2001) 0.92
Activated suppressor cell dysfunction in progressive multiple sclerosis. J Immunol (1986) 0.91
Evolution of the CD8 T-cell repertoire during infections. Microbes Infect (2000) 0.90
Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery (1992) 0.90
Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res (1994) 0.89
Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology (1979) 0.89
Motor neuron disease: decremental responses to repetitive nerve stimulation. Neurology (1981) 0.89
Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol (1999) 0.89
Reduced T-lymphocyte cell reactivity as a function of human aging. Cell Immunol (1980) 0.89
N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study. Ann Neurol (1986) 0.88
Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med (1987) 0.88
Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol (1987) 0.88
Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity. Neurology (1978) 0.88
Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J Neuroimmunol (1998) 0.88
Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology (1999) 0.87
Origin of contralateral reactive gliosis in surgically injured rat cerebral cortex. Brain Res (1991) 0.87
Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol (1982) 0.87
Consequences of cross-reactive and bystander CTL responses during viral infections. Virology (2000) 0.87
Low T8 antigen density on lymphocytes in active multiple sclerosis. Ann Neurol (1984) 0.87
CD95-CD95L: can the brain learn from the immune system? Trends Neurosci (1998) 0.87
Expression of a homologue of rat NG2 on human microglia. Glia (1999) 0.87
Differential expression of heat shock proteins by human glial cells. J Neuroimmunol (1992) 0.86
Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc (1983) 0.86
Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand. Clin Immunol (2002) 0.86
Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience (1998) 0.86
Histocompatibility typing in amyotrophic lateral sclerosis. Arch Neurol (1976) 0.86
Expression of tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol (1996) 0.86
In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol (1998) 0.86
Morphologic heterogeneity of human adult astrocytes in culture: correlation with HLA-DR expression. J Neurosci Res (1990) 0.86
Cytokine induction of heat shock protein expression in human oligodendrocytes: an interleukin-1-mediated mechanism. J Neuroimmunol (1994) 0.86